Human pharmaceuticals are among the most essential and strategic products of Iran’s pharmaceutical industry, covering a wide range of chemical, biological, generic, and specialized medicines.

Iran has strong capabilities in the production of human medicines, particularly generics, many of which meet international standards. The country has also made significant progress in developing biosimilars and oncology drugs, supported by modern facilities and skilled professionals.

Human pharmaceuticals play a vital role in reducing import dependency, saving foreign currency, and improving public access to affordable treatment. The industry also generates employment for specialists in manufacturing, quality control, and R&D sectors.

Iran supplies human medicines to regional and international markets, including Iraq, Afghanistan, Syria, Venezuela, and several African countries. Competitive pricing, acceptable quality, and scalable production capacity serve as key export advantages.

Iran’s competitive advantages include a well-educated workforce, extensive manufacturing infrastructure, proximity to regional markets, and low production costs. Expanding international certifications and strengthening national pharmaceutical branding can further boost Iran’s position in global pharmaceutical exports.